Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit?

Acute myeloid leukemia (AML) is a clinically and genetically heterogenous malignancy of myeloid progenitor cells that affects patients of all ages. Despite decades of research and improvement in overall outcomes, standard therapy remains ineffective for certain subtypes of AML. Current treatment is...

Descripción completa

Detalles Bibliográficos
Autores principales: Wojcicki, Anna V., Kadapakkam, Meena, Frymoyer, Adam, Lacayo, Norman, Chae, Hee-Don, Sakamoto, Kathleen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072462/
https://www.ncbi.nlm.nih.gov/pubmed/32069925
http://dx.doi.org/10.3390/cancers12020441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072462/
https://www.ncbi.nlm.nih.gov/pubmed/32069925
http://dx.doi.org/10.3390/cancers12020441

Ejemplares similares